Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sergio García Rull"'
Autor:
Ángel López-Encuentra, PhD, Pablo Lázaro y de Mercado, PhD, Víctor Abraira, PhD, Sergio García Rull, MD, Francisco Pozo Rodríguez, PhD
Publikováno v:
The Lancet Regional Health. Europe, Vol 3, Iss , Pp 100069- (2021)
Externí odkaz:
https://doaj.org/article/a1a2e0052bc14fb5b747b5ea72829205
Autor:
A. López-Encuentra, Sergio García Rull, Francisco Pozo Rodríguez, Pablo Lázaro y de Mercado, Víctor Abraira
Publikováno v:
The Lancet Regional Health-Europe
The Lancet Regional Health. Europe, Vol 3, Iss, Pp 100069-(2021)
The Lancet Regional Health. Europe, Vol 3, Iss, Pp 100069-(2021)
Autor:
Javier Ortega, Antonio Sueiro, Sergio García-Rull, David Jiménez Castro, Gema Díaz, Carlos Escobar, Joaquin Picher, David Martí
Publikováno v:
Blood Coagulation & Fibrinolysis. 18:173-177
This study aimed to determine whether a weight-adjusted dose of subcutaneous enoxaparin is as effective and safe as oral acenocoumarol for the secondary prophylaxis of pulmonary embolism. Three hundred and eighty consecutive noncancer outpatients hos
Autor:
Antonio Sueiro, Gema Díaz, Carlos Escobar, Joaquin Picher, Sergio García-Rull, Roger D. Yusen, Dolores Taboada, David Jiménez Castro
Publikováno v:
Thrombosis Research. 121:153-158
Study objective To investigate the prognostic significance of a diagnostic delay of greater than 1 week after symptom onset in patients with pulmonary embolism (PE). Design Prospective cohort study. Location Emergency Department of Ramon y Cajal Hosp
Autor:
David Jiménez, Richard Vidal, Antonio Sueiro, Sergio García-Rull, Gema Díaz, Richard W. Light
Publikováno v:
Respiratory Medicine. 100:2048-2052
In pleural infection, it has been recommended that Gram stain and cultures should be obtained on a routine basis. However, this recommendation has not been tested prospectively. We evaluated the yield of microbiological studies in 259 patients with p
Autor:
Richard Vidal, Gema Díaz, David Martí, Carlos Escobar, David Jiménez, José Miguel Molina, J Del Rey, Sergio García-Rull, Antonio Sueiro, Roger D. Yusen
Publikováno v:
The European respiratory journal. 31(4)
The assessment of risk and appropriate treatment of patients with acute pulmonary embolism (PE) remains a challenge. The prognostic performance of cardiac troponin I (cTnI) in predicting 30-day all-cause mortality was prospectively assessed in consec